Dynavax Technologies Corp (NASDAQ:DVAX)

RBC Out With Top Pick Biotech Stocks to Buy for 2018

During the election battle, and for a while after, the health care stocks, including biotechnology and big pharmaceutical, were constantly buffeted by threats over drug pricing and other potential changes ...
Read Full Story »
Female patient on gurney

4 Biopharma Stocks Moving the Market on Wednesday

Markets have hit new intraday highs on Wednesday, continuing to climb in the wake of the White House announcements. Although the health care sector has been attacked by the U.S. ...
Read Full Story »

10 Major Pharma and FDA Catalysts Coming in December

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »

4 Companies That Destroyed Shareholders Last Week

Now that the U.S. presidential election is over and markets have recovered to their highs, there are still some stocks holding back the markets from breaking even higher. 24/7 Wall ...
Read Full Story »
Stock Price

Dynavax, Nokia Tumble into Monday’s 52-Week Low Club

November 14, 2016: Here are four stocks trading with relatively heavy volume among 75 equities making new 52-week lows in Monday's session. On the NYSE, advancers led decliners by less ...
Read Full Story »
tired frustrated unhappy business person

Why Dynavax Shares Are in Freefall

Dynavax Technologies Corp. (NASDAQ: DVAX) shares  crumbled Monday morning after the company said that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA). Specifically ...
Read Full Story »
Stock Price

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Friday's session. NYSE advancers led decliners by nearly 4 to ...
Read Full Story »
Test tubes

4 More Key FDA Decisions in March

24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March. Generally, companies in the pharmaceutical industry are involved in the lengthy ...
Read Full Story »
Stock Price

The 52-Week Low Club for Wednesday

March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday's session. Unisys Corp. (NYSE: UIS) fell by nearly 28% on ...
Read Full Story »
clinical trials

Dynavax Soars on Positive Late Stage Results

Dynavax Technologies Corp. (NASDAQ: DVAX) led the bulls on Thursday with positive results from a late stage clinical trial, on another consecutive down day for the broad markets. The reported ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples, Tyco and More

Stocks were indicated marginally lower and were still looking for direction Monday morning. Still, the S&P 500 was above 2,100 and the Dow Jones Industrial Average was above 18,100 after ...
Read Full Story »
Biotechnology word cloud

After Idenix: The Next Four Biotech Buyout Candidates

Wall Street likes nothing better than to start the week off with a bang, and pharmaceutical giant Merck & Co. Inc. (NYSE: MRK) rang the bell Monday by spending $3.85 ...
Read Full Story »

Top Biotech Stocks Under $5 With Huge Potential Upside

With the top stocks in the market exploding in price due to the recent rally, we wanted to scan across our research universe for some lower priced names that could ...
Read Full Story »

Short Sellers Abandon Key Nasdaq Stocks — Short Covering Galore

Short selling has always been a difficult game. One of the reasons that many investors, both institutional and retail, avoid selling stock short is the potential for loss is unlimited. ...
Read Full Story »

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Anybody that has been long the biotechnology sector for the past four years has had outstanding returns. Following four straight years of outperformance against the S&P 500, investor interest in ...
Read Full Story »